Developing a PBPK modeling approach for evaluating drug product performance in infants based on adults data

Developing a PBPK modeling approach for evaluating drug product performance in infants based on adults data

Software: GastroPlus®
Division: PBPK

Understanding drug and drug formulation performance in relation to the prandial conditions is essential for ensuring the safety and efficacy of products to be administered to pediatric patients, especially newborns...

NAFLDsym Application Showcase: Key Examples of NAFLDsym Use within Drug Development

NAFLDsym Application Showcase: Key Examples of NAFLDsym Use within Drug Development

Software: NAFLDsym®

NAFLDsym is a quantitative systems pharmacology (QSP) modeling software to support the development of treatments for non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Human-on-a-Chip combined with PBPK modeling for in vitro/in vivo PK/PD extrapolation

Human-on-a-Chip combined with PBPK modeling for in vitro/in vivo PK/PD extrapolation

Authors: Hickman J, Lukacova V
Software: GastroPlus®
Division: PBPK

Human-on-a-Chip (HoaC) systems are becoming valuable tools to study, understand disease physiology, and expand the prediction of pharmacodynamic effects before first-in-human studies. They can also be used to evaluate the toxic effects of compounds in non-pharma industries where these effects cannot be examined in vivo.